Skip to main content
Clinical Trials/ACTRN12622001087741
ACTRN12622001087741
Recruiting
未知

Assessing the usability and acceptability of a multiple health behavior change, self-monitoring mobile app for adolescents: A pilot trial of the Health4Life app

HMRC CTC0 sites75 target enrollmentAugust 5, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
poor diet
Sponsor
HMRC CTC
Enrollment
75
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 5, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HMRC CTC

Eligibility Criteria

Inclusion Criteria

  • 1\.Aged 13\-17 years
  • 2\.Living in Australia
  • 3\.Access to a smartphone
  • 4\.Willing to download the Health4Life app

Exclusion Criteria

  • 1\.Aged below 13 years or above 18 years
  • 2\.Not living in Australia
  • 3\.No access to a smartphone
  • 4\.Not willing or unable to download the Health4Life app
  • 5\.Insufficient English literacy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The evaluation of usability, acceptability and immediate outcomes from the use of smartphone application for neck pain self-management in smartphone users with neck paieck painNeck painSmartphone applicationNeck pain self managementSelf managementAlternative therapy
TCTR20190124003Graduate School, Khon Kaen University100
Active, not recruiting
Not Applicable
Evaluating the acceptability and usability of a digital self-management intervention (smartphone application) to support the non-surgical treatment of Perthes' DiseasePerthes' DiseaseMusculoskeletal Diseases
ISRCTN14517832niversity of Leeds30
Recruiting
Not Applicable
Development of a website for family/friends of adults with depressioCarer mental healthDepressionMental Health - Studies of normal psychology, cognitive function and behaviourMental Health - Depression
ACTRN12624000864527Deakin University30
Active, not recruiting
Phase 1
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiency
EUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S
Active, not recruiting
Not Applicable
Evaluating the usability, acceptability and impact of a gamification/mindfulness etool for young peopleThe experience of stress & distress in young people.Mental Health - Other mental health disorders
ACTRN12615001001583Young and Well Cooperative Research Centre270